Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on International Tech Times.
Press releases published on April 8, 2025
Vivex Biologics, Inc. Provides Enrollment Update for its ASCEND Study Examining Whether Supplementing Discs with VIA Disc NP™ Reduces Pain and/or Improves Function in Patients with Symptomatic Disc Degeneration
GlobeNewswire
·
April 8, 2025
MIAMI, April 08, 2025 (GLOBE NEWSWIRE) -- Vivex Biologics, Inc., a leader in developing and delivering innovative allografts, today announced the company has enrolled 50% of the patients in its ASCEND clinical trial for VIA Disc NPTM. The ASCEND study is a …
Aqua Security Achieves FedRAMP® High Authorization
GlobeNewswire
·
April 8, 2025
BOSTON, April 08, 2025 (GLOBE NEWSWIRE) -- Aqua Security, the pioneer in cloud native security, announced today that it has achieved the Federal Risk and Authorization Management Program’s (FedRAMP®) high impact authorization status and is listed in the …
Science 37 Completes Second FDA Inspection as Enrollment Leader in Phase 3 Asthma Trial
GlobeNewswire
·
April 8, 2025
MORRISVILLE, N.C., April 08, 2025 (GLOBE NEWSWIRE) -- Science 37, a leader in enhancing patient access to clinical trials, today announced the successful completion of its second FDA inspection, reaffirming the quality of its Direct-to-Patient Site for …
Clene Presents Evidence of Remyelination and Neuronal Repair With CNM-Au8® Treatment At the American Academy of Neurology Late-Breaking Science Session
GlobeNewswire
·
April 8, 2025
Analyses of MRI and VEP data confirm anatomical and physiological improvements, indicating remyelination and neuronal repair in the brains of MS patients treated with CNM-Au8 during the long-term extension of VISIONARY-MS Over 90% of participants who …
Praxis Precision Medicines to Hold Virtual Investor Event to Discuss Clinical Programs in Developmental and Epileptic Encephalopathies
GlobeNewswire
·
April 8, 2025
BOSTON, April 08, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized …
Opus Genetics Announces One-Month Clinical Data from Pediatric Patient in Phase 1/2 Trial of OPGx-LCA5 Gene Therapy in Inherited Retinal Diseases
GlobeNewswire
·
April 8, 2025
First pediatric patient shows encouraging early safety profile and meaningful improvement in visual function at one month A second pediatric patient was recently dosed, and the pediatric cohort is expected to complete enrollment in Q2 2025; initial data …
Aqua Metals Pioneers Domestic LFP Recycling with Breakthrough Bench-Scale Testing
GlobeNewswire
·
April 8, 2025
RENO, Nev., April 08, 2025 (GLOBE NEWSWIRE) -- Aqua Metals (NASDAQ: AQMS), a pioneer in sustainable lithium battery recycling, today announced the successful completion of bench-scale testing and engineering analysis for a novel process to recycle lithium …
ProStar Announces Global Commercial Strategy with Radiodetection to Deliver Precision Utility Mapping
GlobeNewswire
·
April 8, 2025
GRAND JUNCTION, Colo., April 08, 2025 (GLOBE NEWSWIRE) -- ProStar® Holdings Inc., (“ProStar®” or “the Company”) (TSXV: MAPS) (OTCQX: MAPPF) (FSE: 5D00) the developers of PointMan®, Precision Mapping Solutions® is pleased to announce a Global Commercial …
Adaptive Biotechnologies Receives Expanded Medicare Coverage of clonoSEQ® for Surveillance in Mantle Cell Lymphoma
GlobeNewswire
·
April 8, 2025
SEATTLE, April 08, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease …
Cycurion, Inc. Expands Partnership with Journal Technologies, Secures $22 Million Contract with State Police Agency
GlobeNewswire
·
April 8, 2025
FALLS CHURCH, Va., April 08, 2025 (GLOBE NEWSWIRE) -- Cycurion, Inc. (NASDAQ: CYCU), a trailblazer in advanced cybersecurity and information technology solutions, today announces an expanded partnership with Journal Technologies, a leading provider of case …
Recursion Announces First Patient Dosed in Phase 1 Clinical Study of REC-3565, a Selective MALT1 Inhibitor for Relapsed or Refractory B-cell Lymphomas
GlobeNewswire
·
April 8, 2025
Salt Lake City, UT, April 08, 2025 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, today announced that the first patient has been dosed in the Phase 1 EXCELERIZE clinical …
TransGlobal Assets Inc. (OTC: TMSH) Set to Transform Fintech and Dating with AI-Powered Platforms: Intelligent Debt Solutions and DateGuard
GlobeNewswire
·
April 8, 2025
AI-First Debt Solutions That Prioritize Human Wellness: Intelligent Debt Solutions leverages real-time behavioral analytics and ethical AI to offer highly personalized financial recovery pathways for individuals while boosting efficiency and empathy in …
OilXCoin's Prospectus Secures First Regulatory Approval For A Very Unique Security Token Backed by Oil & Gas
GlobeNewswire
·
April 8, 2025
Geneva, Switzerland, April 08, 2025 (GLOBE NEWSWIRE) -- The Financial Market Authority (FMA) in Liechtenstein has approved the security prospectus for OilXCoin for offering in key EEA jurisdictions and establishing its presence in the Real-World Asset (RWA …
FTC Solar Introduces Revolutionary Dual-Row Configuration for 1P Pioneer Tracker™: Industry’s Highest East-West Slope Tolerance for a linked tracker
GlobeNewswire
·
April 8, 2025
AUSTIN, Texas, April 08, 2025 (GLOBE NEWSWIRE) -- FTC Solar, a leading provider of cutting-edge solar tracker technology, is excited to unveil its latest innovation with the dual-row configuration for the 1P Pioneer Tracker™, setting a new standard in …
Aemetis Biogas Monthly RNG Production Increased by 55% in March
GlobeNewswire
·
April 8, 2025
CUPERTINO, Calif., April 08, 2025 (GLOBE NEWSWIRE) -- Aemetis, Inc. (NASDAQ: AMTX), a renewable natural gas and renewable fuels company focused on low and negative carbon intensity renewable fuels, announced today that its production of renewable natural …
Bionano Announces French Publication of an Effective Method for Analysis of Multiple Myeloma by OGM
GlobeNewswire
·
April 8, 2025
SAN DIEGO, April 08, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced a study published in The Journal of Molecular Diagnostics that describes a method for analysis of multiple myeloma (MM) by optical genome mapping (OGM). MM …
Green Construction Market size to worth USD 780.72 Billion by 2032, says Coherent Market Insights
GlobeNewswire
·
April 8, 2025
Burlingame, CA, April 08, 2025 (GLOBE NEWSWIRE) -- Increasing environmental concerns, stricter regulations on energy efficiency Drives Green Construction Market Growth from USD 375.80 Bn in 2025 Get a Sample Report of Green Construction Market @ https:// …
Jupiter Neurosciences Highlights Upcoming Milestones in Shareholder Letter
GlobeNewswire
·
April 8, 2025
Strategic expansion into longevity market creates near-term commercial opportunity alongside continued clinical advancement of JOTROL™ JOTROL™ development programs remain tariff-exempt; consumer longevity line on track with negligible cost exposure Jupiter …
Nano Dimension Appoints Ofir Baharav as CEO
GlobeNewswire
·
April 8, 2025
Mr. Baharav to Drive Critical Desktop Metal and Markforged Strategic Integration Towards Growth Outlook that Can Deliver Financial Results Robert Pons to Become Chairman of the Board Waltham, Massachusetts, April 08, 2025 (GLOBE NEWSWIRE) -- Nano Dimension …
ZyVersa Therapeutics CEO Issues Shareholder Letter on PARASOL Recommendations Expected to Reduce Drug Development Barrier for Rare Kidney Disease, Focal Segmental Glomerulosclerosis (FSGS)
GlobeNewswire
·
April 8, 2025
WESTON, Fla., April 08, 2025 (GLOBE NEWSWIRE) -- ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA; “ZyVersa”), a clinical stage specialty biopharmaceutical company developing first-in-class drugs for treatment of patients with renal and inflammatory diseases who …